IL17A and Alzheimer disease: In the pathogenesis of AD, the increased IL-17 production is known to activate keratinocytes in AD-like lesions and induce the production of exacerbating factors such as cytokines/chemokines (GM-CSF, TNF-α, IL-8, CXCL10) and VEGF [44].